Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin.
Hanna RM, Streja E, Kalantar-Zadeh K.
Adv Ther. 2021 Jan;38(1):52-75. doi: 10.1007/s12325-020-01524-6. Epub 2020 Oct 29.
Erythropoiesis-stimulating agent hyporesponsiveness.
Johnson DW, Pollock CA, Macdougall IC.
Nephrology (Carlton). 2007 Aug;12(4):321-30. doi: 10.1111/j.1440-1797.2007.00810.x.
Anaemia in CKD-treatment standard.
Macdougall IC.
Nephrol Dial Transplant. 2024 Apr 26;39(5):770-777. doi: 10.1093/ndt/gfad250.
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
Goodkin DA, Zhao J, Cases A, Nangaku M, Karaboyas A.
Am J Nephrol. 2022;53(5):333-342. doi: 10.1159/000523947. Epub 2022 Apr 22.
Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients.
Nangaku M, Mimura I, Yamaguchi J, Higashijima Y, Wada T, Tanaka T.
J Ren Nutr. 2015 Mar;25(2):160-3. doi: 10.1053/j.jrn.2014.10.011. Epub 2014 Dec 30.
Responsiveness to an erythropoiesis-stimulating agent is correlated with body composition in patients undergoing chronic hemodialysis.
Lee HY, Suh SW, Hwang JH, Shin J.
Front Nutr. 2022 Dec 2;9:1044895. doi: 10.3389/fnut.2022.1044895. eCollection 2022.
Erythropoiesis-stimulating agent hyporesponsiveness in end-stage renal disease patients.
Ogawa T, Nitta K.
Contrib Nephrol. 2015;185:76-86. doi: 10.1159/000380972. Epub 2015 May 19.
Effect of roxadustat on serum metabolome and lipidome in patients with end-stage renal disease and erythropoiesis-stimulating agent resistance.
Wang L, Wu Y, Li Y, You L, Liu X, Wang Z, Xiao J, Zhang S, Xu T, Wang X, Li Q, Hu C, Xu G, Liu S.
Ann Transl Med. 2022 Oct;10(19):1069. doi: 10.21037/atm-22-4451.
Roxadustat alleviates the inflammatory status in patients receiving maintenance hemodialysis with erythropoiesis-stimulating agent resistance by increasing the short-chain fatty acids producing gut bacteria.
Zhao XN, Liu SX, Wang ZZ, Zhang S, You LL.
Eur J Med Res. 2023 Jul 10;28(1):230. doi: 10.1186/s40001-023-01179-3.
Association of the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index with cardiovascular mortality in maintenance hemodialysis patients.
Yajima T, Yajima K, Takahashi H.
PLoS One. 2021 Jan 15;16(1):e0245625. doi: 10.1371/journal.pone.0245625. eCollection 2021.
